• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Minimal residual disease analysis in childhood mature B-cell leukaemia/lymphoma treated with AIEOP LNH-97 protocol with/without anti-CD20 administration.

作者信息

Mussolin Lara, Lovisa Federica, Gallingani Ilaria, Cavallaro Elena, Carraro Elisa, Damanti Carlotta C, Vinti Luciana, Sala Alessandra, Micalizzi Concetta, Santoro Nicola, Piglione Matilde, Cellini Monica, Buffardi Salvatore, Buldini Barbara, D'Amore Emanuele S G, Biffi Alessandra, Pillon Marta

机构信息

Division of Pediatric Hematology, Oncology and Stem Cell Transplant, Department of Women and Child Health, University of Padova, Padova, Italy.

Istituto di Ricerca Pediatrica Città della Speranza, Padova, Italy.

出版信息

Br J Haematol. 2020 May;189(3):e108-e111. doi: 10.1111/bjh.16531. Epub 2020 Feb 20.

DOI:10.1111/bjh.16531
PMID:32080837
Abstract
摘要

相似文献

1
Minimal residual disease analysis in childhood mature B-cell leukaemia/lymphoma treated with AIEOP LNH-97 protocol with/without anti-CD20 administration.采用AIEOP LNH - 97方案治疗并接受或未接受抗CD20治疗的儿童成熟B细胞白血病/淋巴瘤的微小残留病分析
Br J Haematol. 2020 May;189(3):e108-e111. doi: 10.1111/bjh.16531. Epub 2020 Feb 20.
2
[High risk acute lymphoblastic leukaemia in children. Preliminary report after introducing a new version of New York (1997) protocol adjusted to the age of the patients. Report of the Polish Paediatric Leukaemia/Lymphoma Study Group].[儿童高危急性淋巴细胞白血病。引入根据患者年龄调整的新版纽约（1997年）方案后的初步报告。波兰儿科白血病/淋巴瘤研究组报告]
Med Wieku Rozwoj. 2000;4(1 Suppl 2):23-32.
3
Randomized assessment of delayed intensification and two methods for parenteral methotrexate delivery in childhood B-ALL: Children's Oncology Group Studies P9904 and P9905.随机评估延迟强化和两种儿童 B-ALL 中肠外甲氨蝶呤给药方法：儿童肿瘤学组研究 P9904 和 P9905。
Leukemia. 2020 Apr;34(4):1006-1016. doi: 10.1038/s41375-019-0642-2. Epub 2019 Nov 14.
4
NUP98-fusion transcripts characterize different biological entities within acute myeloid leukemia: a report from the AIEOP-AML group.NUP98融合转录本可表征急性髓系白血病中的不同生物学实体：来自AIEOP-AML组的报告。
Leukemia. 2017 Apr;31(4):974-977. doi: 10.1038/leu.2016.361. Epub 2016 Nov 28.
5
[Improved results in children with acute lymphoblastic leukemia treated with the ALL-BFM 90 protocol in the Czech Republic].[在捷克共和国采用ALL - BFM 90方案治疗的急性淋巴细胞白血病患儿取得了更好的治疗效果]
Cas Lek Cesk. 2003;142(7):404-9.
6
The analysis of correlations between drug resistance and clinical/laboratory measures found in a group of children with all treated by ALL-BFM 90 protocol.对一组均采用ALL-BFM 90方案治疗的儿童的耐药性与临床/实验室指标之间的相关性进行分析。
Bull Cancer. 2004 Apr;91(4):E80-9.
7
Visualization of Vertebral Body Deformities in Childhood by MRI in a Boy with ALL.一名急性淋巴细胞白血病男孩通过MRI对儿童椎体畸形的可视化
Rofo. 2019 Aug;191(8):752-753. doi: 10.1055/a-0835-6943. Epub 2019 Mar 21.
8
[Molecular genetic detection of minimal residual disease (MRD) in children with acute lymphoblastic leukemia].急性淋巴细胞白血病患儿微小残留病（MRD）的分子遗传学检测
Klin Padiatr. 2013 May;225 Suppl 1:S40-4. doi: 10.1055/s-0033-1337962. Epub 2013 May 22.
9
Cerebrospinal fluid excitatory amino acids and tau protein in children with acute lymphoblastic leukemia treated according to the BFM protocol.按照柏林-法兰克福-明斯特（BFM）方案治疗的急性淋巴细胞白血病患儿的脑脊液兴奋性氨基酸和tau蛋白
Acta Haematol. 2004;112(4):222-4. doi: 10.1159/000081278.
10
Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies.强化治疗在急性淋巴细胞白血病婴儿中的作用：两项连续的意大利儿童血液学和肿瘤学协会（AIEOP）研究结果
Haematologica. 2006 Apr;91(4):534-7. Epub 2006 Mar 15.

引用本文的文献

1
Use of rituximab in mature, high-grade and advanced-stage pediatric B-lineage non-Hodgkin lymphomas: a systematic review, meta-analysis and the Brazilian reality.利妥昔单抗在成熟、高级别和晚期儿童B细胞系非霍奇金淋巴瘤中的应用：一项系统评价、荟萃分析及巴西实际情况
Front Pediatr. 2025 Jan 20;13:1532274. doi: 10.3389/fped.2025.1532274. eCollection 2025.
2
DNA binding domain mutational status and rituximabbased treatment are independent prognostic factors for pediatric Burkitt lymphoma patients stratification.DNA结合域突变状态和基于利妥昔单抗的治疗是小儿伯基特淋巴瘤患者分层的独立预后因素。
Haematologica. 2024 Sep 1;109(9):3031-3036. doi: 10.3324/haematol.2023.284868.
3
Primary breast lymphoma of childhood: a case report and review of literature.
儿童原发性乳腺淋巴瘤：一例报告并文献复习。
BMC Pediatr. 2021 Nov 30;21(1):530. doi: 10.1186/s12887-021-03002-6.
4
Minimal Disease Monitoring in Pediatric Non-Hodgkin's Lymphoma: Current Clinical Application and Future Challenges.儿童非霍奇金淋巴瘤的微小疾病监测：当前临床应用及未来挑战
Cancers (Basel). 2021 Apr 15;13(8):1907. doi: 10.3390/cancers13081907.
5
The Diagnostic Pitfalls of Mucormycosis.毛霉病的诊断陷阱
Mediterr J Hematol Infect Dis. 2020 Nov 1;12(1):e2020079. doi: 10.4084/MJHID.2020.079. eCollection 2020.
6
Self- and Parent-Reported Psychological Symptoms in Young Cancer Survivors and Control Peers: Results from a Clinical Center.青少年癌症幸存者及其同龄人自我报告和家长报告的心理症状：来自一个临床中心的结果。
J Clin Med. 2020 Oct 27;9(11):3444. doi: 10.3390/jcm9113444.